Dyne Therapeutics, Inc. (NASDAQ:DYN) Given Average Recommendation of “Buy” by Analysts
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) has been assigned an average recommendation of “Buy” from the thirteen ratings firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation, ten have given a buy recommendation and two have issued a strong buy recommendation on […]
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) has been assigned an average recommendation of “Buy” from the thirteen ratings firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation, ten have given a buy recommendation and two have issued a strong buy recommendation on […]
